^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SYSA1901 (pertuzumab biosimilar)

    i
    Other names: SYSA1901
    Associations
    News
    Trials
    Company:
    CSPC Pharma
    Drug class:
    HER2 inhibitor
    Related drugs:
    Associations
    News
    Trials